The First Affiliated Hospital of Xiamen University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.xmfh.com.cn
Clinical Trials
Related News

Efficacy and Safety Evaluation of Prebiotics Combined With Quadruple Probiotics in Improving Functional Constipation.

First Posted Date
2024-02-26
Last Posted Date
2024-05-01
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
60
Registration Number
NCT06277505
Locations
🇨🇳

The First Affiliated Hospital of Xiamen Univisity, Xiamen, Fujian, China

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Phase 3
Not yet recruiting
Conditions
Ovarian Cancer
Interventions
Drug: Fluzoparib Capsules
Drug: Apatinib Mesylate Tablets
First Posted Date
2024-01-03
Last Posted Date
2024-01-03
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
37
Registration Number
NCT06188455

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors

First Posted Date
2024-01-03
Last Posted Date
2024-12-18
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
90
Registration Number
NCT06188468
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma

First Posted Date
2023-12-06
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
33
Registration Number
NCT06158386
Locations
🇨🇳

Bing Xu, Xiamen, Fujian, China

AZA Combined With RCHOP in P53-mutated DLBCL.

First Posted Date
2023-12-06
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
52
Registration Number
NCT06158399
Locations
🇨🇳

Bing Xu, Xiamen, Fujian, China

All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

First Posted Date
2023-12-06
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
25
Registration Number
NCT06158412
Locations
🇨🇳

Bing Xu, Xiamen, Fujian, China

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

First Posted Date
2023-11-30
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
33
Registration Number
NCT06151106
Locations
🇨🇳

The First Affiliated Hosptial of Xiamen University, Xiamen, Fujian, China

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

First Posted Date
2023-11-30
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
38
Registration Number
NCT06151080
Locations
🇨🇳

Bing Xu, Xiamen, Fujian, China

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

First Posted Date
2023-11-30
Last Posted Date
2023-12-11
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
90
Registration Number
NCT06151119
Locations
🇨🇳

Bing Xu, Xiamen, Fujian, China

Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic Patients

First Posted Date
2023-11-28
Last Posted Date
2023-11-28
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
100
Registration Number
NCT06147752
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy